Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL675651 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL7601322 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL6383668 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL6036466 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL17555384 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL4453244 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL8505699 | 1.00 | CA2 (0.43) | — | |
| Phosphoric Acid SCHEMBL6393520 | 0.96 | CA2 (0.40) | — | |
| Phosphoric Acid SCHEMBL4138989 | 0.96 | CA2 (0.40) | — | |
| Phosphoric Acid SCHEMBL11300975 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118330072-A | Method for detecting content of related substances in 2, 2-dithiophene methyl glycolate by using high performance liquid chromatography | 南京联智医药科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-116124908-A | Detection method of valsartan hydrochlorothiazide preparation | 山东新时代药业有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-111233944-B | High performance liquid phase method for simultaneously preparing and separating four lignans components | 宝鸡市辰光生物科技有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-111675741-A | Separation method for simultaneously obtaining four kinds of epimedium rare flavone by using preparative liquid phase method | 遵义医科大学 | 2020-09-18 | — | — | CN | claimed |
| CN-111505159-A | Detection method of related substances in arotinolol hydrochloride | 石家庄格瑞药业有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-111233944-A | High performance liquid phase method for simultaneously preparing and separating four lignans components | 宝鸡市辰光生物科技有限公司 | 2020-06-05 | — | — | CN | claimed |
| CN-110187032-A | The measuring method of Pinoresinol diglucoside content in a kind of Eucommia ulmoides | 贵州联盛药业有限公司 | 2019-08-30 | — | — | CN | claimed |
| CN-105866297-B | A kind of HPLC analytical method of the pomalidomide in relation to substance | 合肥久诺医药科技有限公司 | 2019-01-04 | — | — | CN | claimed |
| CN-104606226-B | Anti-inflammation Chinese medicine suppository and preparation method thereof and quality control method | 赵树生 | 2017-12-05 | — | — | CN | claimed |
| CN-104606225-B | A kind of anti-inflammation traditional Chinese herb medicine and preparation method thereof and quality control method | 赵树生 | 2017-06-16 | — | — | CN | claimed |
| CN-102091118-A | Quality detection method for rhodiola crenulata | UNIV CHENGDU TRAD CN MEDICINE | 2011-06-15 | — | — | CN | claimed |
| CN-101961342-A | Water soluble vitamin composition for injection and preparation method thereof | HUI QI | 2011-02-02 | — | — | CN | claimed |
| CN-101780146-A | Quality control method of Biqi capsules | TIANJIN DARENTANG JINGWANHONG | 2010-07-21 | — | — | CN | claimed |
| CN-101708208-A | Quality control method of capsule preparation for treating a painful swollen joint | GUIZHOU MINZU PHARMACEUTICAL C | 2010-05-19 | — | — | CN | claimed |
| CN-101532994-A | Method for measuring content of brain-strengthening and kidney-tonifying preparation | JUNHUA YAO | 2009-09-16 | — | — | CN | claimed |
| CN-1958002-A | Quality control method of lignum naucleae medicinal material intermediate and injection | HAINAN PHARMACEUTICAL FACTORY (CN) | 2007-05-09 | — | — | CN | claimed |
| CN-1305512-C | Traditional Chinese medicine compound recipe for treating hyperplasia of mammary glands and preparation method thereof | BEIJING RONGCHANG PHARMACEUTIC (CN) | 2007-03-21 | — | — | CN | claimed |
| CN-1876028-A | Pharmaceutical preparation for treating coronary heart disease, its preparation process and quality control method | GUIYANG YUNYAN XICHUANG PHARM (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1836666-A | Water-soluble vitamin for injection and its preparation process and quality control method | SHANDONG LUYE PHARM CO LTD (CN) | 2006-09-27 | — | — | CN | claimed |
| CN-1689626-A | Traditional Chinese medicine compound recipe for treating hyperplasia of mammary glands and preparation method thereof | BEIJING RONGCHANG PHARMACEUTIC (CN) | 2005-11-02 | — | — | CN | claimed |